“chemoprevention”的搜索结果，显示 431-440 项，共有 7791 项

1. 血液科- 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz., Rochester, Minn. This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy.

3. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, ...

4. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn., Scottsdale/Phoenix, Ariz. This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies ...

5. 外科 - 临床试验- 妙佑医疗国际

   The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients who have been ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...

7. 放射科- 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The purpose of this study is to evaluate plasma biomarkers of vascular function and inflammation in patients with newly-diagnosed Obstructive ...

8. 乳腺癌- 医生与科室- 妙佑医疗国际

   了解这种常见的癌症，包括有关预防、症状、诊断和治疗的信息。

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...